ArticleOxidative medicine and cellular longevity2019

Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study.

Hamidreza Badeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.